These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6632287)

  • 21. Dual precipitation method: distribution of cholesterol and triglycerides in diagnosis of hyperlipoproteinemia.
    Kotlicka J; Bobilewicz D
    Z Med Lab Diagn; 1986; 27(7):366-71. PubMed ID: 3811474
    [No Abstract]   [Full Text] [Related]  

  • 22. [Use of the Ilca method for cholesterol determination in different types of hyperlipoproteinemia].
    Korovkin BF; Karpishchenko AI; Servuk IuA; Perfil'eva SI
    Voen Med Zh; 1983 Jan; (1):62-3. PubMed ID: 6836943
    [No Abstract]   [Full Text] [Related]  

  • 23. The plasma lipoproteins in familial chylomicronemia. Analysis by zonal ultracentrifugation.
    Manzato E; Marin R; Gasparotto A; Baggio G; Fellin R; Crepaldi G
    J Lab Clin Med; 1984 Nov; 104(5):778-88. PubMed ID: 6491471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypercholesterolemia in childhood.
    West RJ; Lloyd JK
    Adv Pediatr; 1979; 26():1-34. PubMed ID: 396772
    [No Abstract]   [Full Text] [Related]  

  • 25. [The relation between lipoprotein fractions, sex and IHD in patients with primary hyperlipoproteinemia].
    Hora C; Hanefeld M; Leonhardt W; Jacob F; Haller H
    Z Gesamte Inn Med; 1982 Dec; 37(23):801-4. PubMed ID: 7164523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hyperlipoproteinemia in primary gout and asymptomatic hyperuricemia].
    Kullich W; Ulreich A; Klein G
    Wien Med Wochenschr; 1988 May; 138(10):221-5. PubMed ID: 3407202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of diet and drug therapy on the level of high density lipoprotein cholesterol in patients with primary hyperlipoproteinemia].
    Padosh D; Kustosh D; Puchok I; Dem'ianova N; Audikovski M
    Klin Med (Mosk); 1981 Sep; 59(9):45-8. PubMed ID: 7311430
    [No Abstract]   [Full Text] [Related]  

  • 28. [The effect of lovastatin therapy on the dynamics of the clinical state of patients with ischemic heart disease and hyperlipoproteinemia].
    Zhukova IM; Iurenev AP; Pomerantsev EV; Martynov AA; Shabalkin BV; Titov VN; Shimbaeva NA; Kotkina AA; Bochkova EI; Lediashova GA
    Ter Arkh; 1990; 62(8):130-3. PubMed ID: 2274859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [HDL, HDL2 and HDL3 cholesterol in various types of hyperlipoproteinemia in relation to clinical signs of arteriosclerosis].
    Sznajderman M; Zawadzki Z
    Kardiol Pol; 1986; 29(3):194-203. PubMed ID: 3773408
    [No Abstract]   [Full Text] [Related]  

  • 30. [Physiopathology of the process of cholesterol esterification].
    Opincaru A; Vlaicu R; Tapalagă D; Cucuianu M
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1979; 31(3):193-200. PubMed ID: 41301
    [No Abstract]   [Full Text] [Related]  

  • 31. [Granulocyte function and lipid peroxidation in untreated patients with hyperlipoproteinemia].
    Varga Z; Paragh G; Kárpáti I; Seres I; Buris L; Kakuk G
    Orv Hetil; 1997 Sep; 138(36 Suppl 2):2301-4. PubMed ID: 9340576
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Study of lipid metabolic coefficient K2 in patients with hyperlipoproteinemia type IV before and after reduction of triglyceride level by adapted diet therapy].
    Drouin P; Lambert D; Mejean L; Pointel JP; Debry G
    Nutr Metab; 1979; 23(5):416-28. PubMed ID: 225702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The therapeutic efficacy of bezafibrate in hyperlipoproteinemias of various types].
    Noseda G; Fragiacomo C; Weidmann P; Bachmann C
    Schweiz Med Wochenschr; 1980 Dec; 110(49):1875-7. PubMed ID: 7455660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Lipanor treatment of atherogenic hyperlipoproteinemia].
    Susekov AV; Tvorogova MG; Arabidze GG; Kukharchuk VV
    Ter Arkh; 1998; 70(9):57-61. PubMed ID: 9821228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Use of apolipoprotein B subfractionation for the detection of catabolic disorders of intestinal lipoproteins].
    Bergmann S; Jaross W; Schulze J
    Z Med Lab Diagn; 1986; 27(2):64-70. PubMed ID: 3705703
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical research on the hypolipidemic action of a probucol preparation].
    Naumova R; Kerekovska M; Goranov I; Balabanski L
    Vutr Boles; 1986; 25(2):73-7. PubMed ID: 3716382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Dietetics and the prevention of hyperlipoproteinemias].
    Oromi Durich J; Coronas Alonso R; Canela Arqués R; González Fusté F
    Rev Sanid Hig Publica (Madr); 1986; 60(11-12):1109-18. PubMed ID: 3629153
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of halofenate on triglyceride and uric acid levels, coagulation and platelet behaviour in patients with hyperlipoproteinemia type IV and hyperuricemia (author's transl)].
    Kuntzen O; Hehl FJ; Walter E; Zimmermann R
    Arzneimittelforschung; 1978; 28(12):2349-52. PubMed ID: 227420
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of dyslipoproteinemia with the use of plasma total cholesterol and triglyceride as screening tests. The Lipid Research Clinics Program Prevalence Study.
    Kwiterovich PO; Stewart P; Probstfield JL; Stinnett S; Chambless LE; Chase GA; Jacobs DR; Morrison JA
    Circulation; 1986 Jan; 73(1 Pt 2):I30-9. PubMed ID: 3940681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The relation between plasma fibrinogen, blood hematocrit and exercise ST segment depressions in hyperlipoproteinemia.
    Olsson AG; Blombäck M; Ekelund LG
    Artery; 1980; 7(3):215-23. PubMed ID: 7469795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.